NASDAQ NMS - GLOBAL MARKET · HCWB
+1.83% · +$0.0400 · Vol Not reported
Pre-market · updated 04:50:22 ET
HCW Biologics Inc

HCW Biologics Inc

Biotechnology
$2.22
Card
Relationship Map

Veridion Score

BETAMEDIUM CONF · 5/6 factorsMethodology
Earnings absence reason unknown
HCWB
HCW Biologics Inc
Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
SELL BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

40/ 100
Veridion Score
SELL BIAS · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5/6 factors with data · Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is HCWB moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading HCWB catalysts
About HCW Biologics Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2021
Employees
35
Country
US

HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$2.18
Last session
Day high
$2.18
Last session
Day low
$2.18
Last session
Previous close
$2.18
52W high
$36.12
-93.85% from high
52W low
$1.61
2% of range
Market cap
$4M
EPS
$-20.0200
Beta
1.05
Shares out
1.8M
Avg volume
111.2K
VWAP
$2.18
Last session
Price history computed in-house
1W
-11.90%
1M
-11.20%
3M
-85.88%
1Y
-89.28%
YTD
-61.88%
SMA 50 $4.26 · below
SMA 200 $6.50 · below
52W position 2%

HCWB overview

Veridion Score
40
Registered · 2026-08-21
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around HCWB.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading HCWB Form 4 filings
Public disclosures

Congress activity in HCWB

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for HCWB in the cached public ledger.

Federal contracts

HCWB contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for HCWB in this window.
Lobbying spend

HCWB lobbying filings, year to date.

Registered lobbying filings matched to HCW Biologics Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for HCWB in this window.
Loading news for HCWB
Analyst ratings
Sovereign unlock shows live analyst consensus for HCWB.
Options
Sovereign unlock shows live options positioning for HCWB.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.